# Amgen Inc. (AMGN) — Q3-2012 Earnings Results

**Report date:** 2012-10-23 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2012

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Down 0.55%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.67 | N/A | +17.19% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed confidence in their product pipeline and emphasized the importance of innovation. They also acknowledged market challenges.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They noted ongoing investments in R&D to drive future growth.

### Guidance Changes

No guidance was provided in this earnings report.

### What It Means

Amgen's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell slightly by 0.55%, likely due to the lack of revenue information and guidance. Investors may be cautious given the absence of forward-looking statements.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2012_